Tsumura USA

Industry · 9 registered clinical trials.

Status	Trial	Phase	Started
Completed	Safety and Efficacy of TU-100 as an Adjunct to an Enhanced Recovery After Surgery in Subjects Undergoing Bowel Enhanced Recovery After Surgery	Phase 2	2021-07-29
Completed	Effect of TU-100 in Patients Undergoing Laparoscopic Colectomy Postoperative Ileus	Phase 2	2014-09-01
Completed	A Safety and Efficacy Study of Daikenchuto (TU-100) to Relieve Abdominal Bloating in Female Subjects With Irri Irritable Bowel Syndrome in Females	Phase 2	2014-07-01
Completed	Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS) Irritable Bowel Syndrome, Digestive System Diseases, Gastrointestinal Diseases	Phase 1 / Phase 2	2013-08-01
Terminated	A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease Crohn's Disease	Phase 2	2011-09-01
Completed	Effect of TU-100 in Patients With Functional Constipation Functional Constipation	Phase 2	2011-09-01
Completed	Effect of TU-100 on Rectal Compliance, Rectal Sensation and Small Bowel and Colonic Transit in Females With Co Functional Constipation, Gastric Emptying, Whole Gut Transit	Phase 1 / Phase 2	2010-08-01
Completed	Effect of TU-100 on Gastrointestinal and Colonic Transit in Humans Postoperative Ileus	Phase 1 / Phase 2	2009-06-01
Completed	A Tolerability and Efficacy Study of TU-100 For The Treatment of Postoperative Ileus Postoperative Ileus	Phase 2	2005-12-01